Ma, Ting Martin http://orcid.org/0000-0002-0053-7874
Kishan, Amar U. http://orcid.org/0000-0002-7437-6591
Funding for this research was provided by:
American Society for Radiation Oncology
Article History
Received: 25 August 2022
Revised: 2 September 2022
Accepted: 26 September 2022
First Online: 11 October 2022
Competing interests
: AUK reports consulting fees and speaking honoraria from Varian Medical Systems, ViewRay, and Boston Scientific; equity in ViewRay; and research funding from ViewRay outside the scope of the MIRAGE trial. AUK also reports research support from Janssen and Point Biopharma outside the scope of the current work.
Free to read: This content has been made available to all.